Chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma
Author:
Funder
NCI
Duke Cancer Institute
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference111 articles.
1. CAR models: Next-generation CAR modifications for enhanced T-cell function;Abate-Daga;Molecular Therapy—Oncolytics,2016
2. Strategies to address chimeric antigen receptor tonic signaling;Ajina;Molecular Cancer Therapeutics,2018
3. Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination;Akahori;Blood,2018
4. T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma;Ali;Blood,2016
5. Updated results from the phase I CRB-402 study of anti-Bcma CAR-T cell therapy bb21217 in patients with relapsed and refractory multiple myeloma: Correlation of expansion and duration of response with T cell phenotypes;Alsina;Blood,2020
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies;Recent Patents on Anti-Cancer Drug Discovery;2024-12
2. Role of Immune Cells and Immunotherapy in Multiple Myeloma;Life;2024-04-01
3. In Vitro Functionality and Endurance of GMP-Compliant Point-of-Care BCMA.CAR-T Cells at Different Timepoints of Cryopreservation;International Journal of Molecular Sciences;2024-01-23
4. Oncolytic vaccinia virus and cancer immunotherapy;Frontiers in Immunology;2024-01-12
5. Progress and prospect of ASCT combined with CAR-T therapy in the treatment of multiple myeloma;Therapeutic Advances in Hematology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3